Exelixis Inc

Exelixis Inc Stock

20.41P/E
€14.64BMarket capitalisation
US$3.34Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Exelixis Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Exelixis Inc stock.

Market capitalisation
€14.64B
P/E
20.41
P/B
3.00
P/S
7.23
P/CF
13.61
Issued shares 244M Units

Return

Here you can see the performance of the Exelixis Inc stock.

PeriodPerfor­mance
1 Week+12.70 %
1 Month+19.36 %
3 Months+2.24 %
6 Months+22.98 %
1 Year+33.16 %
YTD+22.98 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Exelixis Inc share.

DateRatio
No data available.

Which ETF contains the Exelixis Inc stock?

The Exelixis Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Exelixis Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Exelixis Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.